Matrix Capital Management Company, LP reported 1 positions worth $46.31M for the quarter ended Mar 31, 2026, down 19.6% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 1. Its largest holding is Aura Biosciences, Inc. at 100% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | -480.0K | -100.0% | $19.89M | Exited |
No new positions this quarter.
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | -480.0K | $19.89M | 34.52% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | AURA Aura Biosciences, Inc. | Healthcare | 6.92M | $46.31M | 100% | 0 | 0.0% | Unchanged | 10.26% |
Tip. Select a row to see that position’s full history at Matrix Capital Management Company.
As of its Q1 2026 13F filing, Matrix Capital Management Company, LP’s five largest positions were Aura Biosciences, Inc. (AURA) at 100.0% of the reported portfolio.
Matrix Capital Management Company, LP reported a 13F portfolio worth $46.31M across 1 positions for Q1 2026. That is down 19.6% from the previous quarter.
Its largest sales by value were Maze Therapeutics, Inc. ($19.89M). It exited 1 positions entirely.
From the Form 13F-HR reports Matrix Capital Management Company, LP files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.